QUAKER BIOVENTURES
Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the life science industry, including biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals, and healthcare services. Quaker BioVentures invests in companies at all stages of development, from early stage start-ups to public companies. Founded in 2003, the firm is currently investing Quaker BioVentures II, a $420 million fund formed in 2007. Quaker BioVentures manages over $700 million in committed capital.
QUAKER BIOVENTURES
Social Links:
Industry:
Biotechnology Life Science Venture Capital
Founded:
2002-01-01
Status:
Active
Contact:
215-988-6800
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Apps For Business Microsoft Azure DNS Mimecast Liquid Web Register.com DNS
Similar Organizations
Amkey Ventures
Amkey Ventures is a California-based VC firm, and their mission is to identify investment opportunities by focusing on cutting-edge
ARCH Venture Partners
ARCH is an early-stage venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Bio-Green Planet
Biotech company engaging in R&D and manufacture of microbial products used for in crop yield enhancement and waste & wastewater treatment
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Columbia Ventures
Columbia Ventures is a venture capital firm based in Vancouver that finances early stage investments of the telecommunications industry.
CTI Life Sciences Fund
CTI makes venture capital investments mostly in biotech companies at the pre-clinical and clinical development stages.
Hatteras Funds
Hatteras Funds provides an array of unique alternative investment solutions. A boutique alternative investment specialist founded in 2003,
Kansas Bioscience Authority
Kansas has the largest concentration of animal health companies in the world. Their researchers are making breakthroughs in oncology,
Pandect Bioventures
Pandect Bioventures is venture capital firm providing seed to Series A and later funding to early-stage biotech and pharma companies.
Pittsburgh Life Sciences Greenhouse
The Pittsburgh Life Sciences Greenhouse (PLSG) provides capital investments and customized company formation and business growth services
SCP Vitalife Partners
SCP Vitalife Partners is a venture capital firm focused on life science investments in Israel and the U.S.
Trace Analytics
Trace Analytics offers air testing solutions like compressed air testing, breathing air testing, and microbial testing to different sectors.
WPSS.bio
WPSS.bio is a venture capital firm that invests in revolutionary diagnostics and treatments for central nervous system health.
Yasuda Enterprise Development
Yasuda Enterprise Development, a venture capital firm, finances technology companies based in Japan, the United States, and other countries.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-03-20 | Kaarta | Quaker BioVentures investment in Series A - Kaarta | 6.5 M USD |
| 2015-04-27 | Neuronetics | Quaker BioVentures investment in Series F - Neuronetics | 34.3 M USD |
| 2013-09-23 | PreCision Dermatology | Quaker BioVentures investment in Debt Financing - PreCision Dermatology | 67 M USD |
| 2013-04-29 | RainDance Technologies | Quaker BioVentures investment in Series E - RainDance Technologies | 20.33 M USD |
| 2012-09-05 | Intact Vascular | Quaker BioVentures investment in Series A - Intact Vascular | 15.5 M USD |
| 2012-03-16 | Tarsa Therapeutics | Quaker BioVentures investment in Series B - Tarsa Therapeutics | 28 M USD |
| 2011-06-27 | NovaSom | Quaker BioVentures investment in Series D - NovaSom | 35 M USD |
| 2011-05-16 | Neuronetics | Quaker BioVentures investment in Series E - Neuronetics | 30 M USD |
| 2011-01-25 | RainDance Technologies | Quaker BioVentures investment in Series D - RainDance Technologies | 37.5 M USD |
| 2011-01-04 | TetraLogic Pharmaceuticals | Quaker BioVentures investment in Series C - TetraLogic Pharmaceuticals | 23 M USD |